BioNTech SE

A series of mega-blockbuster drugs are on the horizon. How to invest in the trend
Biopharma companies are having more clinical success treating Alzheimer’s disease and obesity and are taking new approaches in oncology, and that’s creating more mega-blockbuster drugs, according to Bank of America. Analyst Geoff Meacham has identified 20 drugs that have the potential to generate $10 billion or more in annual sales by 2030 within the universe […]
Read More
Covid vaccination linked to slight increase in menstrual cycle, NIH study confirms
A healthcare worker administers a dose of the Pfizer-BioNTech Covid-19 vaccine at a vaccination clinic in the Peabody Institute Library in Peabody, Massachusetts, U.S., on Wednesday, Jan. 26, 2022. Vanessa Leroy | Bloomberg | Getty Images Covid-19 vaccination is linked to a slight increase in the length of a women’s menstrual cycle, delaying the beginning […]
Read More
Stocks producing the most significant moves midday: Change Health care, Ford, PayPal, Humana and more
In this posting GM F LVS NVAX MRNA BNTX Ford Motor Firm’s electric F-150 Lightning on the manufacturing line at their Rouge Electric Motor vehicle Centre in Dearborn, Michigan on September 8, 2022. Jeff Kowalsky | AFP | Getty Images Test out the organizations creating headlines in midday investing Tuesday. Transform Healthcare – Shares of […]
Read More
Stocks making the largest moves in the premarket: Ford, Improve Health care, Cognex and more
observe now Video:5200:52 Wall Avenue set to open up in the purple as Fed kicks off September conference Early morning Report Get a look at some of the major movers in the premarket: Ford (F) – The automaker’s stock fell 4.5% in the premarket right after it warned that quarterly earnings would acquire a hit […]
Read More
Deutsche Bank upgrades Moderna, says strong second-quarter results set up the stock for big gain ahead
Strong second-quarter results from Moderna make now an opportune time to buy shares of the biotechnology company, Deutsche Bank said. Analyst Emmanuel Papadakis upgraded shares of the Covid-19 vaccine maker to buy, citing quarterly numbers that beat analyst expectations . Papadakis also pointed to additional contracts unaccounted for in the company’s previous guidance and a […]
Read More
Omicron boosters are a key milestone, but aren’t likely to woo new investors to Pfizer, Moderna
It’s a new milestone in the Covid-19 pandemic. People will soon roll up their sleeves and get jabbed with a booster shot tailored to the dominant coronavirus strain circulating in the U.S. Health officials have suggested this is likely to become a new pattern, joining the annual ritual of the flu shot. “For the first […]
Read More
Moderna sues Pfizer/BioNTech for patent infringement about Covid vaccine
The Moderna Covid-19 vaccine awaits administration at a vaccination clinic in Los Angeles, California on December 15, 2021. Frederic J. Brown | AFP | Getty Visuals Moderna is suing Pfizer and its German spouse BioNTech for patent infringement in the enhancement of the initial Covid-19 vaccine permitted in the United States, alleging they copied technologies […]
Read More
FDA plans to authorize bivalent boosters by Labor Day, sources say
In this photo illustration, vials and a medical syringe seen in front of the Food and Drug Administration (FDA) of the United States and Pfizer Pharmaceutical company logos. FDA approves Pfizer/BioNTech the COVID-19 coronavirus vaccine for emergency use in the US, reportedly by media. Pavlo Gonchar | AP The Food and Drug Administration plans to […]
Read More
Pfizer asks FDA to authorize Covid booster shots that target omicron BA.5 for people ages 12 and older
In this photo illustration, vials and a medical syringe seen in front of the Food and Drug Administration (FDA) of the United States and Pfizer Pharmaceutical company logos. FDA approves Pfizer/BioNTech the COVID-19 coronavirus vaccine for emergency use in the US, reportedly by media. Pavlo Gonchar | AP Pfizer and its German partner BioNTech on […]
Read More